Flow diagram outlining various factors that can alter market size and share for precision medicines

FIGURE 2-1A number of factors influence the market potential for targeted therapeutics with the prospect of reduced market size leading to increased market share

NOTE: As defined by Trusheim et al. (2007), an empirical medicine, as opposed to a stratified medicine, is not developed based upon the characteristics of an individual or a subpopulation of individuals. These medicines are based on overall population response and may work for a large or a small amount of individuals without using (either because it is not necessary or one is not available) a methodology to identify which groups may respond.

SOURCE: Trusheim et al., 2007.

From: 2, The Current Landscape

Cover of Genome-Based Therapeutics
Genome-Based Therapeutics: Targeted Drug Discovery and Development: Workshop Summary.
Institute of Medicine (US).
Washington (DC): National Academies Press (US); 2012.
Copyright © 2012, National Academy of Sciences.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.